Palvella Therapeutics (PVLA) Change in Cash (2013 - 2026)
Palvella Therapeutics (PVLA) reported Change in Cash of $148.4 million for Q1 2026, up 1960.73% year-over-year from $7.2 million in Q1 2025, and up 2757.33% quarter-over-quarter from -$5.6 million in Q4 2025.
Palvella Therapeutics (PVLA) Change in Cash (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of Change in Cash data on file, last reported at $148.4 million in Q1 2026.
- Change in Cash for Q1 2026 came in at $148.4 million, up 1960.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $130.8 million (up 88.49% YoY), and the FY2025 annual result was -$25.6 million, down 133.6% from the prior year.
- Change in Cash grew to $148.4 million in Q1 2026 per PVLA's latest filing, from -$5.6 million in the prior quarter.
- Over five years, Change in Cash peaked at $148.4 million in Q1 2026 and troughed at -$34.0 million in Q1 2022.
- A 5-year average of $6.5 million and a median of -$5.2 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash surged 2442.84% in 2024, then plunged 1980.61% in 2025.
- A 5-year view of Change in Cash shows it stood at -$9.8 million in 2022, then soared by 69.74% to -$3.0 million in 2023, then surged by 2442.84% to $69.4 million in 2024, then plunged by 108.05% to -$5.6 million in 2025, then soared by 2757.33% to $148.4 million in 2026.
- Business Quant data shows PVLA's Change in Cash at $148.4 million in Q1 2026, -$5.6 million in Q4 2025, and -$6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - | 148.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.41 Mn |
| Dec 31, 2025 | -5.59 Mn |
| Sep 30, 2025 | -6.87 Mn |
| Jun 30, 2025 | -5.19 Mn |
| Mar 31, 2025 | -7.98 Mn |
| Dec 31, 2024 | 69.40 Mn |
| Sep 30, 2024 | -330,000.00 |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | -2.96 Mn |
| Sep 30, 2023 | -12.04 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | -9.79 Mn |
| Sep 30, 2022 | -5.83 Mn |
| Jun 30, 2022 | -29.48 Mn |
| Mar 31, 2022 | -34.03 Mn |
| Dec 31, 2021 | -7.29 Mn |
| Sep 30, 2021 | 5.96 Mn |
| Jun 30, 2021 | 52.26 Mn |